Value of the CD25+ CD16+ cell determination in defining the prognosis of operable breast cancer patients

R. V. Iaffaioli, G. Frasci, L. Rinaldi, L. Del Vecchio, A. Tortoriello, G. Facchini, V. Perone, V. Montesarchio, C. Vacca, F. Vaia, A. R. Bianco

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Value of the CD25+ CD16+ cell determination in defining the prognosis of operable breast cancer patients'. Together they form a unique fingerprint.

Medicine & Life Sciences